Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

The New Rule 1.510 - Radical Change for Summary Judgement Procedure in Florida

Client Alert

In civil litigation, where both sides participate actively, trial is usually required at the end of a long, expensive case to determine a winner and a loser. In federal and most state courts, however, there are a few procedural shortcuts by which parties can seek to prevail in advance of trial, saving time, money and annoyance. The most common of these is the “motion for summary judgment”: a request to the court by one side for judgment before trial, generally on the basis that the evidence available reflects that a win for that party is legally inevitable and thus required. Effective May 1, 2021, summary judgment procedure in Florida has radically changed.

Like most states, Florida’s Rules of Civil Procedure are patterned on the Federal Rules. The summary judgment standard under Rule 1.510 allowed for summary judgment only in the absence of a “genuine issue as to any material fact”. This articulation of the summary judgment standard was nearly identical to federal Rule 56, which references any “genuine dispute as to any material fact…” (emphasis supplied). Under the Florida standard, the trial court would evaluate the “summary judgment evidence” of record as of the hearing to determine whether any genuine factual issues existed. The judge looked at the evidence on the hearing date; the judge was not to weigh the evidence or evaluate the credibility of witnesses at summary judgment.

Florida courts interpreted this standard as requiring the movant to disprove the opponent’s case in order to prevail at summary judgment. The courts also defined “genuine issue” of material fact to emphasize that virtually any suggestion that the summary judgment opponent could plausibly offer any evidence in opposition would suffice to defeat the motion. This allowed summary judgment opponents to overcome the motion in the great majority of cases by filing any evidence in advance of the hearing. Even preposterous claims and ludicrous defenses could usually survive summary judgment and force trial.

By contrast, the federal courts interpreted the Rule 56 standard as mirroring the one judges use in deciding motions for directed verdict—in which the court considers, at the end of the evidence, whether to submit the case to the jury or instead, whether the evidence so overwhelmingly favors one party that as a matter of law, that side must prevail. In making this determination at the earlier summary judgment stage, federal courts necessarily engage in more discretionary evaluation of the evidence and its ultimate persuasive effect, rather than simply a quantitative measuring whether any evidence exists in favor of the non-movant. For decades, scholars and many practitioners have expressed frustration with Florida summary judgment practice and suggested that the federal standard be adopted.

That day has come: on December 31, 2020, The Florida Supreme Court issued In Re: Amendments to Florida Rule of Civil Procedure 1.510, Case No. SC20-1490. On April 29, 2021, the Court further altered its opinion following input from the legal community. The Court amended the rule specifically to adopt the United States Supreme Court’s summary judgment standard articulated in three opinions from 1986 known as “the Celotex trilogy”. The majority opinion reviewed the history of Florida and federal practice and the divergence between them despite the near identical language in the Florida and federal rules.

The Court rewrote Rule 1.510 to track federal Rule 56 almost completely. It mandated trial courts state on the record the reasons for granting or denying motions for summary judgment. The Court increased the time periods for filing motions and filing oppositional materials, and pinpointed the precise means by which the movant, opponent and trial judge may reference the summary judgment evidence in the record. The Court clarified that the trial court can consider things in the record beyond what the parties argued, or even render an order granting summary judgment for a party who had not sought it or on grounds not raised, even on the trial judge’s own initiative. The Court gave trial judges authority to sanction summary judgment opponents who file materials in bad faith or solely for delay, through an award of attorneys’ fees or contempt.

Justice Labarga dissented, cautioning that loosening the standard would likely impair the constitutional right to trial and noting that “when the more relaxed federal interpretation is applied to a motion for summary judgment, the trial court’s analysis goes far beyond evaluating whether an issue of material fact is in dispute. Instead, the trial court assumes a role traditionally reserved for a jury and engages in weighing evidence.” SC20-1490 at 9 (Labarga, J., dissenting).

The rule change is effective May 1 and applies to motions filed and pending but not yet ruled upon as of that date: within the past week, a trial judge rendered an order on a summary judgment motion I had argued in March, still pending as of May 1, declining to rule and ordering resubmissions under the new standard. That will be only the first of many unexpected and significant effects of this new rule for me and for all civil practitioners in Florida.

For additional questions, please contact Litigation Member Scott Rost at srrost@bmdllc.com.


Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.